|
|
Volumn 25, Issue 2, 2013, Pages 259-260
|
|
Cancer immunotherapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
B RAF KINASE INHIBITOR;
CANCER VACCINE;
CHIMERIC ANTIGEN RECEPTOR;
HLA ANTIGEN;
INTERFERON;
IPILIMUMAB;
LYMPHOCYTE ANTIGEN RECEPTOR;
MELANOMA ANTIGEN 3;
MONOCLONAL ANTIBODY;
PD 1 ANTIGEN;
SIPULEUCEL T;
T LYMPHOCYTE ANTIGEN;
UNCLASSIFIED DRUG;
ADOPTIVE TRANSFER;
ADVANCED CANCER;
BREAST CANCER;
CANCER IMMUNOTHERAPY;
CD8+ T LYMPHOCYTE;
COLORECTAL CANCER;
DRUG APPROVAL;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LUNG NON SMALL CELL CANCER;
MELANOMA;
OVARY CANCER;
PROSTATE CANCER;
T LYMPHOCYTE ACTIVATION;
TREATMENT RESPONSE;
TUMOR ASSOCIATED LEUKOCYTE;
TUMOR MICROENVIRONMENT;
HUMANS;
IMMUNOTHERAPY;
NEOPLASMS;
T-LYMPHOCYTES;
|
|
EID: 84877070912
PISSN: 09527915
EISSN: 18790372
Source Type: Journal
DOI: 10.1016/j.coi.2013.03.008 Document Type: Editorial |
|
Times cited : (18)
|
|
References (0)
|
